Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07419347
Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
The objective of this study is to assess the safety, tolerability and effectiveness of 8-week Glecaprevir/Pibrentasvir (G/P) in participants taking either prescribed or illicit drugs.
Official title: Retrospective Analysis of Glecaprevir/Pibrentasvir Safety and Concomitant Medications Through Integrated Real-World Data
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2026-02-27
Completion Date
2026-06
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Locations (2)
Vancouver Infectious Diseases Centre /ID# 275313
Vancouver, British Columbia, Canada
St. Clair Medical Clinic /ID# 275334
Toronto, Ontario, Canada